Ключевые слова:
peptic ulcer disease, etiology, pathogenesis, Helicobacter pylori, individualized therapy, personalized approach, prevention of recurrence, gastroprotective agents.Библиографические ссылки
Vasilenko V.Kh. What do we not know about peptic ulcer disease (ways to study the problem). In: Current Issues of Gastroenterology. Moscow, 1970, Issue 3: 3-17.
Warren J.R., Marshall B.J. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1983; 1: 1311-13 15.
Isakov V.A., Domaradsky I.V. Helicobacteriosis. Moscow; 2003.
Schwartz K. Contributions on penetrating gastric and jejunal ulcers. Clinical Surgery. 1910; 57: 96-128.
Graham D.Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 1989; 96 (Suppl.): 615-625.
Fennerty M.B., Kovacs T.O., Krause R. et al. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. Archives of Internal Medicine. 1998; 158: 1651-1656.
Meucci G., Di Battista R., Abbiati C. et al. Prevalence and risk factors of Helicobacter pylori-negative peptic ulcer: A multicenter study. Journal of Clinical Gastroenterology. 2000; 31: 42-47.
Bytzer P., Taglbjaerd P.S. Helicobacter pylori-negative duodenal ulcer: Prevalence, clinical characteristics and prognosis. Results from a randomized trial with 2-year follow-up. American Journal of Gastroenterology. 2001; 96: 1409-1416.
Laine L., Hopkins R., Gerardi L. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. American Journal of Gastroenterology. 1998; 93(9): 1409-1415.
Baranskaya E.K. Peptic ulcer disease and Helicobacter pylori infection. Russian Medical Journal. 2000; 1: 8-14.
Minushkin O.N., Aronova O.V. Modern view on the problem of Helicobacter pylori eradication. Practicing Doctor. 2002; 1: 52-54.
Tytgat G.N.J. No Helicobacter pylori, no Helicobacter pylori-associated peptic ulcer disease. Alimentary Pharmacology & Therapeutics. 1995; 9 (Suppl. 1): 39-42.
Tytgat G.N.J. Treatment of peptic ulcer. Digestion. 1998; 59 (5): 446-452.
Zimmerman Y.S., Vedernikov V.E., Novikov V.N., Kasyanova N.L. Microflora of the duodenal mucosa and its role in the pathogenesis of peptic ulcer relapse. Siberian Journal of Gastroenterology and Hepatology. 2001; 12-13: 61-63.
Chernyin V.V., Chervinets V.M., Bonda renko V.M., Bazlov S.N. Peptic ulcer, chronic gastritis and esophagitis in the aspect of dysbiosis of the esophagogastroduodenal zone. Tver; 2004.
Bondarenko V.M., Matsulevich T.V. Intestinal dysbiosis as a clinical and laboratory syndrome. Moscow; 2007.
Chervinets V.M., Bazlov S.N., Chernyin V.V., Strelets E.V. Microflora of the periulcerous zone in patients with peptic ulcer disease and its sensitivity to antibacterial drugs. Experimental and Clinical Gastroenterology. 2002; 1: 37-39.
Tkachenko E.I. Endogenous biocenosis as a factor in the development of internal organ diseases. Experimental and Clinical Gastroenterology. 2003; 1: 167-168.
Zimmerman Y.S. Human and Helicobacter pylori: the concept of interaction. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 1998 ;5 (Suppl. 5): 64-65.
Zimmerman Y.S., Zinnatullin M.R. The concept of interaction between the human body and Helicobacter pylori. Clinical Medicine. 1998; 2: 52-56.
Blaser M.J. Cost of commensalism (state of the lecture). In: 6th United European Gastroenterology Week. 1997; Abstracts and Discussion.
Blaser M.J. Helicobacter are indigenous to the human stomach: Duodenal ulceration is due to changes in gastric microecology in the modern era. Gut. 1998; 43: 721-727.
Blaser M.J. Helicobacter pylori: Balance and imbalance. European Journal of Gastroenterology & Hepatology. 1998; 10: 15-18.
Blaser M.J. Helicobacter pylori and gastric disease. British Medical Journal. 1998; 316: 1507-1510.
Laine L., Schoenfeld P., Fennerty M.B. Therapy for Helicobacter pylori in patients with non-ulcer dyspepsia: A meta-analysis of randomized, controlled trials. Annals of Internal Medicine. 2001; 134: 361-369.
Hamlet A., Thoresen A.-C.E., Nilsson O. et al. Duodenal Helicobacter pylori infection differs in CagA-genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology. 1998; 116(2): 259-268.
Go M.F. Helicobacter pylori infection: Is there a connection between the microorganism genotype and disease presence? In: Diagnosis and Treatment of Diseases Associated with Helicobacter pylori. 2nd International Symposium. Moscow; 1999: 2-3.
Zimmerman Y.S. The problem of etiology and pathogenesis of peptic ulcer disease: Re-reading V.Kh. Vasilenko. Clinical Medicine. 2011; 1: 14-19.
Sipponen P. Chronic gastritis and ulcer risk. Scandinavian Journal of Gastroenterology. 1990 ; 22(2): 105-107.
Kekki M., Sipponen P., Suirala M., Laszewicz W. Peptic ulcer and chronic gastritis: Their relation to age and sex, and to location of ulcer and gastritis. Gastroenterology Clinical Biology. 1990; 14(3): 217-223.
Niemala S., Karttunen T., Kerola T. Helicobacter pylori-associated gastritis: Evolution of histologic changes over 10 years. Scandinavian Journal of Gastroenterology. 1995; 30: 342-349.
Chereshnev V.A. Immune molecular-cellular mechanisms of inflammation. Perm; 2004.
Zimmerman Y.S., Mikhaleva E.N. Peptic ulcer disease and the immune system of the body. Clinical Medicine. 2000; 7: 15-21.
Goodwin C.D. Duodenal ulcer, Campylobacter pylori and the 'Leaking roof' concept. Lancet. 1988; 2: 1467-1469.
Шодикулова Г. З., Шоназарова Н. Х., Шеранов А. М. Характеристика коморбидного ревматоидного артрита и гипотиреоза //Достижения науки и образования. – 2022. – №. 3 (83). – С. 88-91.
Vasilenko V.Kh. Introduction to the Clinic of Internal Diseases. Moscow; 1985: 64.
Aruin L.I. Helicobacter pylori in the etiology and pathogenesis of peptic ulcer disease. In: Materials of the 7th Session of the Russian Group for the Study of Helicobacter pylori. Nizhny Novgorod; 1998: 6-9.
Zimmerman Y.S. Etiology, pathogenesis, and treatment of peptic ulcer disease associated with Helicobacter pylori infection: The current state of the problem and prospects. Clinical Medicine. 2006; 3: 9-19.
Zimmerman Y.S. The concept of the pathogenesis of peptic ulcer disease (justification). Clinical Medicine. 1994; 4: 65-67.
Sudakov K.V. Functional systems of the body in the dynamics of pathological conditions. Clinical Medicine. 1997; 10: 4-11.
Шеранов А. М., Таджиев Ф. С., Джаббарова Н. М. Особенности клинического течения хронической обструктивной болезни легких у больных гериатрического возраста в Самаркандском регионе //Тюменский медицинский журнал. – 2013. – Т. 15. – №. 2. – С. 32-33.
Kryzhanovsky T.N. Dysregulatory Pathology. Moscow; 2002.
Saltykov A.B. The theory of functional systems and clinical medicine. Clinical Medicine. 2008; 1: 4-9.
Serov V.V. General pathological approa-ches to understanding diseases. Saratov; 1992.
Chernukh A.M. Predisease, onset of disease, and recovery (general pathological aspects of the problem). In: 18th All-Union Congress of Therapists. Moscow; 1981; Vol. 1: 118-121.
Gubergrits M.M. On the clinic of peptic ulcer disease (1949). Selected Works. Kiev; 1959: 337-352.
Gorbatovsky Ya.A., Esheva L.A., Filimonov S.N. et al. Genetic markers in patients with duodenal peptic ulcer disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 1998; 4: 24-27.
Suadocani P., Hein H.O., Gyntelber F. Genetic and lifestyle determinants of peptic ulcer: A study of 3387 men aged 54 to 74 years. Scandinavian Journal of Gastroenterology. 1999; 34: 12-17.